![Vaccines | Free Full-Text | Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II | HTML Vaccines | Free Full-Text | Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II | HTML](https://www.mdpi.com/vaccines/vaccines-09-00565/article_deploy/html/images/vaccines-09-00565-g001.png)
Vaccines | Free Full-Text | Immunogenicity and Safety of Inactivated Sabin-Strain Polio Vaccine “PoliovacSin”: Clinical Trials Phase I and II | HTML
Original Contribution Paralytic Poliomyelitis Associated With Sabin Monovalent and Bivalent Oral Polio Vaccines in Hungary
Vaccine-Associated Paralytic Poliomyelitis in the Postelimination Era in Latin America and the Caribbean, 1992-2011
![SciELO - Brasil - Uso universal da vacina inativada contra poliomielite Uso universal da vacina inativada contra poliomielite SciELO - Brasil - Uso universal da vacina inativada contra poliomielite Uso universal da vacina inativada contra poliomielite](https://minio.scielo.br/documentstore/1678-4782/xdBXn9R65JdNQJmwdbSmybs/20e4340c4b24ddf2c038d4440570d9122bbda5ab.gif)
SciELO - Brasil - Uso universal da vacina inativada contra poliomielite Uso universal da vacina inativada contra poliomielite
![Poliomyelitis eradication and poliovirus laboratory containment - GAPIII (Global Action Plan III) | Belgian Biosafety Server Poliomyelitis eradication and poliovirus laboratory containment - GAPIII (Global Action Plan III) | Belgian Biosafety Server](https://www.biosafety.be/sites/default/files/fig_gapiii_2015_en.jpg)
Poliomyelitis eradication and poliovirus laboratory containment - GAPIII (Global Action Plan III) | Belgian Biosafety Server
![The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/aa76d7b6-4372-4635-beb2-d41797fad1d2/gr1_lrg.gif)
The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study - The Lancet
![SciELO - Saúde Pública - Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive SciELO - Saúde Pública - Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive use of oral polio vaccine Vaccine-associated paralytic poliomyelitis in India during 1999: decreased risk despite massive](https://www.scielosp.org/media/assets/bwho/v80n3/a07t05.gif)